Vitamin B12 deficiency often first appears as skin changes like hyperpigmentation, dryness, or paleness, indicating poor oxygen and nutrient delivery to skin cells. These visible signs, including ...

Overall and event-free survival of 100 and 95%, respectively, seen with autologous CD34+ hematopoietic stem-cell lentiviral gene therapy. HealthDay News — Autologous CD34+ hematopoietic stem-cell ...

An investigational gene therapy showed sustained clinical efficacy for children born with ADA-SCID. In a study of 62 children, overall survival after treatment was 100% and event-free survival was 95% ...

NEW YORK – Researchers from the University of California, Los Angeles (UCLA) and University College London (UCL) are preparing to seek regulatory approvals in the US and UK for a gene therapy they ...

Severe combined immunodeficiency due to adenosine deaminase deficiency, or ADA-SCID, is caused by mutations in the ADA gene, which creates an enzyme essential for immune function. For children with ...

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and instead ...

As a dietitian, I’ve seen how easily vitamin K deficiency can go unnoticed. This essential nutrient often takes a backseat to more popular vitamins like C and D, but its role in your health is just as ...

Nearly a quarter of Americans are estimated to have a vitamin D deficiency. Why is that? A 2022 study of National Health and Nutrition Examination Surveys (NHANES) data estimated that about 22% of ...

The Department of Justice (DOJ) on Wednesday removed what it called “outdated” and “unnecessary” red tape for businesses to comply with the Americans with Disabilities Act (ADA). The department ...

- Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of disease, including survival, heart function, and stabilization ...

NEW YORK – Researchers from the University of California, Los Angeles, and University College London are advancing a gene therapy they say could be a cure for severe combined immunodeficiency due to ...